Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 14, 2005; 11(6): 908-911
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.908
Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats
Lin Jia, Mei-Hua Zhang
Lin Jia, Department of Digestive Diseases, Affiliated First People’s Municipal Hospital, Guangzhou Medical College, Guangzhou 510180, Guangdong Province, China
Mei-Hua Zhang, Department of Digestive Diseases, Affiliated First People’s Municipal Hospital, Guangzhou Medical College, Guangzhou 510180, Guangdong Province, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Lin Jia, Department of Digestive Diseases, First People’s Municipal Hospital of Guangzhou, 1 Panfu Road, Guangzhou 510180, Guangdong Province, China. gzjialin@hotmail.com
Telephone: +86-20-81628877 Fax: +86-20-81628809
Received: June 4, 2004
Revised: June 7, 2004
Accepted: July 15, 2004
Published online: February 14, 2005
Abstract

AIM: To compare the efficacy of probiotic preparation Golden Bifid and lactulose on rat experimental model of minimal hepatic encephalopathy (MHE) induced by thioactamide (TAA).

METHODS: MHE was induced by intraperitoneal injection of TAA (200 mg/kg) every 24 h for two consecutive days. Thirty-six male MHE models were then randomly divided into 3 groups: TAA group (n = 12) received tap water ad libitum only; lactulose group (n = 12) and probiotics group (n = 12) were gavaged, respectively with 8 mL/kg of lactulose and 1.5 g/kg of probiotic preparation Golden Bifid (highly concentrated combination of probiotic) dissolved in 2 mL of normal saline, once a day for 8 d (from the 5th d before the experiment to the 3rd d of the experiment). The latency of brainstem auditory evoked potentials (BAEP) I was used as an objective index of MHE. The incidence of MHE, the level of serum endotoxin, ammonia, liver function and histological grade of hepatic injury of rats were examined individually.

RESULTS: There were no overt HE and rat deaths in 3 groups. The incidence of MHE, the levels of blood ammonia and endotoxin in TAA group, which were 83.3% (10/12), 168.33±15.44 mg/dL and 0.36±0.04 EU/mL, respectively, were significantly higher than those in lactulose group, which were 33.3% (4/12), 110.25±7.39 mg/dL and 0.19±0.02 EU/mL, and probiotics group, which were 33.3% (4/12), 108.58±10.24 mg/dL and 0.13±0.03 EU/mL respectively (P <0.001). It showed that either probiotics or lactulose could significantly lower the level of hyperammonemia and hyper-endotoxemia, lighten centrolobular necrotic areas as well as inflammatory reaction in the liver of rats, normalize the latency of BAEP, and decrease the incidence of MHE. However, no significant differences were observed between these two groups (P >0.05).

CONCLUSION: Probiotic compound Golden Bifid is at least as useful as lactulose for the prevention and treatment of MHE. Probiotic therapy may be a safe, natural, well-tolerated therapy appropriate for the long-term treatment of MHE.

Keywords: Minimal hepatic encephalopathy, Probiotics, Lactulose